Australian-based SUDA has entered into a definitive agreement to buy NovaDel Pharma's NovaMist technology and certain other assets. The transaction, as contemplated, does not include intellectual property or licenses of NovaDel's ...
Tags: SUDA, Novadel Pharma Novamist